TFF Pharmaceuticals Investor Relations Material
Latest events
Study Update
TFF Pharmaceuticals
Q3 2024
20 Nov, 2024
Q2 2024
14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TFF Pharmaceuticals Inc
Access all reports
TFF Pharmaceuticals Inc develops and commercializes innovative inhalable therapeutics using its proprietary Thin Film Freezing technology. Its focus areas include respiratory diseases, infectious diseases, and immunology. The company is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
TFFP
Country
🇺🇸 United States